Learn More
Invitrogen™ LILRA3 Polyclonal Antibody

Description
In direct ELISAs, approximately 30% cross-reactivity with recombinant human (rh) ILT2, rhILT4, ILT5 is observed, and less than 5% cross-reactivity with rhLIR5 and rhLIR7 is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
Specifications
Specifications
| Antigen | LILRA3 |
| Applications | Flow Cytometry |
| Classification | Polyclonal |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative |
| Gene | LILRA3 |
| Gene Accession No. | Q8N6C8 |
| Gene Alias | CD85 antigen-like family member E; CD85e; HM31; HM43; ILT6; ILT-6; Immunoglobulin-like transcript 6; leucocyte Ig-like receptor A3; leukocyte immunoglobulin like receptor A3; leukocyte immunoglobulin-like receptor 4; leukocyte immunoglobulin-like receptor A3; leukocyte immunoglobulin-like receptor subfamily A member 3; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3; LILRA3; LIR4; LIR-4; Monocyte inhibitory receptor HM43/HM31 |
| Gene Symbols | LILRA3 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.